サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1546187

血管イメージングの世界市場

Vascular Imaging

出版日
ページ情報
英文 182 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
血管イメージングの世界市場
出版日: 2024年09月03日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 182 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

血管イメージングの世界市場は2030年までに119億米ドルに到達

2023年に86億米ドルと推定される血管イメージングの世界市場は、分析期間2023-2030年にCAGR 4.7%で成長し、2030年には119億米ドルに達すると予測されます。本レポートで分析しているセグメントの1つであるMRIは、CAGR 4.8%を記録し、分析期間終了までに55億米ドルに達すると予測されています。CTセグメントの成長率は、分析期間でCAGR 4.9％と推定されます。

米国市場は23億米ドル、中国はCAGR 8.3％で成長予測

米国の血管イメージング市場は2023年に23億米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに27億米ドルの市場規模に達すると予測され、分析期間2023-2030年のCAGRは8.3%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ1.6%と4.9%と予測されています。欧州では、ドイツがCAGR 2.1%で成長すると予測されています。

世界の血管イメージング市場- 主要動向と促進要因まとめ

血管イメージング技術の採用を促進するものは何か？

血管イメージング技術は、血管や循環系の詳細な可視化を提供し、血管疾患の診断や管理に不可欠なものとなっています。心血管および末梢血管疾患の有病率の増加により、超音波、磁気共鳴血管造影（MRA）、コンピュータ断層撮影（CTA）などの高度な画像診断モダリティの需要が急増しています。これらの技術は血管の状態に関する重要な洞察を提供し、早期診断、正確な治療計画、効果的な疾患進行のモニタリングを可能にします。ヘルスケアプロバイダーが患者の予後を改善し、血管疾患の負担を軽減しようと努力する中、血管イメージング技術の採用は拡大し、市場拡大を牽引すると予想されます。

技術の進歩は血管イメージングをどのように強化しているか？

技術の進歩は血管イメージングの能力を大幅に向上させ、より正確で非侵襲的、そして利用しやすいものにしました。高解像度画像システムと造影剤の開発により、血管画像の鮮明さと細部が改善され、異常や閉塞をよりよく検出できるようになりました。人工知能（AI）と機械学習アルゴリズムのイメージング・システムへの統合は、自動画像解析と予測診断を可能にし、この分野をさらに革新しました。さらに、携帯型画像診断装置やポイントオブケア画像診断装置の技術革新により、特に遠隔地や十分なサービスを受けていない地域でも、血管イメージングがより身近なものとなった。このような技術の進歩は、血管疾患の診断と管理においてより高い精度と利便性を提供するため、血管イメージング技術の普及を後押ししています。

血管イメージングの新たな動向とは？

血管イメージング市場には、その成長と開拓を形作るいくつかの新興動向が見られます。1つの顕著な動向は、PET/CTやPET/MRIのようなハイブリッドイメージング技術の使用の増加です。もう一つの動向は、侵襲的処置に伴う患者の不快感や合併症のリスクを軽減する必要性から、非侵襲的画像診断法を重視する傾向が強まっていることです。また、個別化医療に対する需要の高まりも市場に影響を与えており、個々の患者のプロファイルに基づいて治療計画を調整するために画像技術が使用されるようになってきています。さらに、AI主導の画像解析の利用拡大により、血管画像をより正確かつ迅速に解釈できるようになり、診断精度と効率が向上しています。

血管イメージング市場の成長を促進する要因とは？

血管イメージング市場の成長は、アテローム性動脈硬化症、動脈瘤、深部静脈血栓症などの血管疾患の有病率の上昇など、いくつかの要因によって牽引されています。また、予防ヘルスケアの重要性に対する意識の高まりに後押しされた、早期かつ正確な診断に対する需要の高まりも大きな推進力となっています。さらに、より高度で非侵襲的な画像診断システムの開発など、画像診断技術の絶え間ない進歩により、ヘルスケアプロバイダーが利用できる診断オプションの幅が広がっています。患者の予後改善と医療費削減における正確な診断の重要性を強調する価値観に基づく医療へのシフトは、血管イメージング技術の採用をさらに後押ししています。さらに、血管イメージング分野の研究開発への注目が高まっており、政府のイニシアティブや資金援助によって支えられていることも、市場の成長に寄与しています。

調査対象企業の例（注目の18社）

  • Abbott Laboratories
  • Carestream Health, Inc.
  • Esaote SpA
  • Fujifilm Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shimadzu Medical Systems USA
  • Siemens AG
  • Terumo Corporation
  • Toshiba Corporation

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP15455

Global Vascular Imaging Market to Reach US$11.9 Billion by 2030

The global market for Vascular Imaging estimated at US$8.6 Billion in the year 2023, is expected to reach US$11.9 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2023-2030. MRI, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$5.5 Billion by the end of the analysis period. Growth in the CT segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 8.3% CAGR

The Vascular Imaging market in the U.S. is estimated at US$2.3 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.7 Billion by the year 2030 trailing a CAGR of 8.3% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.6% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Vascular Imaging Market - Key Trends & Drivers Summarized

What Is Driving the Adoption of Vascular Imaging Technologies?

Vascular imaging technologies have become indispensable in the diagnosis and management of vascular diseases, offering detailed visualizations of blood vessels and circulatory systems. The increasing prevalence of cardiovascular and peripheral vascular diseases has led to a surge in the demand for advanced imaging modalities such as ultrasound, magnetic resonance angiography (MRA), and computed tomography angiography (CTA). These technologies provide critical insights into vascular conditions, enabling early diagnosis, precise treatment planning, and effective monitoring of disease progression. As healthcare providers strive to improve patient outcomes and reduce the burden of vascular diseases, the adoption of vascular imaging technologies is expected to grow, driving market expansion.

How Are Technological Advancements Enhancing Vascular Imaging?

Technological advancements have significantly enhanced the capabilities of vascular imaging, making it more accurate, non-invasive, and accessible. The development of high-resolution imaging systems and contrast agents has improved the clarity and detail of vascular images, allowing for better detection of abnormalities and blockages. The integration of artificial intelligence (AI) and machine learning algorithms into imaging systems has further revolutionized the field, enabling automated image analysis and predictive diagnostics. Additionally, innovations in portable and point-of-care imaging devices have made vascular imaging more accessible, particularly in remote or underserved regions. These technological advancements are driving the widespread adoption of vascular imaging technologies, as they offer greater precision and convenience in the diagnosis and management of vascular diseases.

What Are the Emerging Trends in Vascular Imaging?

The vascular imaging market is witnessing several emerging trends that are shaping its growth and development. One notable trend is the increasing use of hybrid imaging techniques, such as PET/CT and PET/MRI, which combine the strengths of different imaging modalities to provide more comprehensive and accurate assessments of vascular conditions. Another trend is the growing emphasis on non-invasive imaging methods, driven by the need to reduce patient discomfort and the risk of complications associated with invasive procedures. The rise in demand for personalized medicine is also influencing the market, as imaging technologies are increasingly being used to tailor treatment plans based on individual patient profiles. Furthermore, the expanding use of AI-driven imaging analytics is enabling more precise and faster interpretation of vascular images, improving diagnostic accuracy and efficiency.

What Factors Are Driving the Growth of the Vascular Imaging Market?

The growth in the vascular imaging market is driven by several factors, including the rising prevalence of vascular diseases such as atherosclerosis, aneurysms, and deep vein thrombosis. The increasing demand for early and accurate diagnosis, fueled by the growing awareness of the importance of preventive healthcare, is also a significant driver. Additionally, the continuous advancements in imaging technologies, including the development of more sophisticated and non-invasive imaging systems, are expanding the range of diagnostic options available to healthcare providers. The shift towards value-based care, which emphasizes the importance of accurate diagnostics in improving patient outcomes and reducing healthcare costs, is further boosting the adoption of vascular imaging technologies. Moreover, the growing focus on research and development in the field of vascular imaging, supported by government initiatives and funding, is contributing to the market's growth.

Select Competitors (Total 18 Featured) -

  • Abbott Laboratories
  • Carestream Health, Inc.
  • Esaote SpA
  • Fujifilm Corporation
  • GE Healthcare
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • Koninklijke Philips NV
  • Samsung Medison Co., Ltd.
  • Shimadzu Medical Systems USA
  • Siemens AG
  • Terumo Corporation
  • Toshiba Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Vascular Imaging - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Non-invasive Imaging Techniques
    • Technological Advancements in Vascular Ultrasound
    • Growth of MRI and CT Angiography in Vascular Diagnostics
    • Adoption of AI and Machine Learning in Vascular Imaging Analysis
    • Increasing Use of Portable and Handheld Imaging Devices
    • Expanding Applications of Vascular Imaging in Disease Screening
    • Innovations in Contrast Media and Imaging Agents
    • Integration of Imaging with Vascular Interventional Procedures
    • Growing Awareness and Early Diagnosis of Vascular Conditions
    • Cost-effectiveness and Accessibility of New Imaging Modalities
    • Rising Prevalence of Cardiovascular Diseases Globally
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Vascular Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for MRI by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for MRI by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for CT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for CT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for X-Ray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for X-Ray by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for X-Ray by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Ultrasound by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Ultrasound by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Nuclear Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Nuclear Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Vascular Imaging Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Therapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Therapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • JAPAN
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • CHINA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • EUROPE
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Vascular Imaging by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • FRANCE
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • GERMANY
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Vascular Imaging by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • INDIA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 121: India 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Vascular Imaging by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Vascular Imaging by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Vascular Imaging by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030
  • AFRICA
    • Vascular Imaging Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Vascular Imaging by Technique - MRI, CT, Ultrasound, Nuclear Imaging and X-Ray Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Vascular Imaging by Technique - Percentage Breakdown of Value Sales for MRI, CT, Ultrasound, Nuclear Imaging and X-Ray for the Years 2014, 2024 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Vascular Imaging by Application - Diagnostics and Therapeutics - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Vascular Imaging by Application - Diagnostics and Therapeutics Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Vascular Imaging by Application - Percentage Breakdown of Value Sales for Diagnostics and Therapeutics for the Years 2014, 2024 & 2030

IV. COMPETITION